CYCC Price Targets and Analyst Ratings NASDAQ:CYCC
CYCC Forecast. What You Should Know.
CYCC Historical Ratings and Targets
About Cyclacel Pharmaceuticals
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases. The company's development programs include fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and CYC140, a polo-... CYCC Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.